OBJECTIVE: Understanding how best to measure renal function in HIV-infected patients is critical because estimated glomerular filtration rate (eGFR) in HIV-infected patients can be affected by ethnicity and body composition. We validated the available eGFR equations and compared them to the plasma Tc-diethylenetriaminepentaacetic acid (Tc-DTPA) clearance in HIV-infected patients. DESIGN: Test of diagnostic accuracy. METHODS: One hundred and ninety-six HIV-infected patients underwent measuring of Tc-DTPA plasma clearance, five creatinine-based eGFR equations, cystatin-C GFR, and 24-h urine creatinine clearance (CrCl). RESULTS: Mean (SD) Tc-DTPA GFR was 117.7 ± 29.2 ml/min per 1.73 m. The re-expressed Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), re-expressed MDRD formula with Thai racial correction factor, Thai eGFR equation, Cockcroft-Gault equation, cystatin-C GFR, and 24-h urine CrCl underestimated the reference GFR. The bias estimated by the mean of differences (SD) for the re-expressed MDRD equation, CKD-EPI, re-expressed MDRD formula with Thai racial correction factor, Thai eGFR, Cockcroft-Gault equation, cystatin-C, and 24-h urine CrCl can be expressed as 18.9 ± 27.3, 11.1 ± 25.5, 6.2 ± 28.8, 15.4 ± 27.0, 30.4 ± 28.0, 3.2 + 36.1, and 5.0 ± 12.1 ml/min per 1.73 m, respectively. CONCLUSION: The available eGFR equations underestimated GFR in HIV-infected adults. However, the eGFR by cystatin-C GFR was the most precise and accurate. Among creatinine-based eGFR equations, re-expressed MDRD formula with Thai racial correction factor was the most precise and accurate. The racial factor for each ethnicity is important and the existing eGFR equation should be validated before using it in the HIV population.
OBJECTIVE: Understanding how best to measure renal function in HIV-infectedpatients is critical because estimated glomerular filtration rate (eGFR) in HIV-infectedpatients can be affected by ethnicity and body composition. We validated the available eGFR equations and compared them to the plasma Tc-diethylenetriaminepentaacetic acid (Tc-DTPA) clearance in HIV-infectedpatients. DESIGN: Test of diagnostic accuracy. METHODS: One hundred and ninety-six HIV-infectedpatients underwent measuring of Tc-DTPA plasma clearance, five creatinine-based eGFR equations, cystatin-C GFR, and 24-h urine creatinine clearance (CrCl). RESULTS: Mean (SD) Tc-DTPA GFR was 117.7 ± 29.2 ml/min per 1.73 m. The re-expressed Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), re-expressed MDRD formula with Thai racial correction factor, Thai eGFR equation, Cockcroft-Gault equation, cystatin-C GFR, and 24-h urine CrCl underestimated the reference GFR. The bias estimated by the mean of differences (SD) for the re-expressed MDRD equation, CKD-EPI, re-expressed MDRD formula with Thai racial correction factor, Thai eGFR, Cockcroft-Gault equation, cystatin-C, and 24-h urine CrCl can be expressed as 18.9 ± 27.3, 11.1 ± 25.5, 6.2 ± 28.8, 15.4 ± 27.0, 30.4 ± 28.0, 3.2 + 36.1, and 5.0 ± 12.1 ml/min per 1.73 m, respectively. CONCLUSION: The available eGFR equations underestimated GFR in HIV-infected adults. However, the eGFR by cystatin-C GFR was the most precise and accurate. Among creatinine-based eGFR equations, re-expressed MDRD formula with Thai racial correction factor was the most precise and accurate. The racial factor for each ethnicity is important and the existing eGFR equation should be validated before using it in the HIV population.
Authors: R J Macisaac; C Tsalamandris; M C Thomas; E Premaratne; S Panagiotopoulos; T J Smith; A Poon; M A Jenkins; S I Ratnaike; D A Power; G Jerums Journal: Diabetologia Date: 2006-05-03 Impact factor: 10.122
Authors: Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente Journal: Ann Intern Med Date: 2006-08-15 Impact factor: 25.391
Authors: Kedar Joshi; David Boettiger; Stephen Kerr; Takeshi Nishijima; Kinh Van Nguyen; Penh Sun Ly; Man Po Lee; Nagalingeswaran Kumarasamy; Wingwai Wong; Pacharee Kantipong; Do Duy Cuong; Adeeba Kamarulzaman; Jun Yong Choi; Fujie Zhang; Romanee Chaiwarith; Oon Tek Ng; Sasisopin Kiertiburanakul; Benedict Lim Heng Sim; Tuti Parwati Merati; Evy Yunihastuti; Rossana Ditangco; Jeremy Ross; Sanjay Pujari Journal: Pharmacoepidemiol Drug Saf Date: 2018-09-24 Impact factor: 2.890
Authors: Lesley A Inker; Christina Wyatt; Rebecca Creamer; James Hellinger; Matthew Hotta; Maia Leppo; Andrew S Levey; Aghogho Okparavero; Hiba Graham; Karen Savage; Christopher H Schmid; Hocine Tighiouart; Fran Wallach; Zipporah Krishnasami Journal: J Acquir Immune Defic Syndr Date: 2012-11-01 Impact factor: 3.731
Authors: Aghogho A Okparavero; Hocine Tighiouart; Zipporah Krishnasami; Christina M Wyatt; Hiba Graham; James Hellinger; Lesley A Inker Journal: Antivir Ther Date: 2013-08-20
Authors: Willemijn L Eppenga; Matthijs van Luin; Clemens Richter; Hieronymus J Derijks; Peter A G M De Smet; Michel Wensing Journal: J Nephrol Date: 2013-12-20 Impact factor: 3.902
Authors: Todd H Driver; Rebecca Scherzer; Carmen A Peralta; Phyllis C Tien; Michelle M Estrella; Chirag R Parikh; Anthony W Butch; Kathryn Anastos; Mardge H Cohen; Marek Nowicki; Anjali Sharma; Mary A Young; Alison Abraham; Michael G Shlipak Journal: AIDS Date: 2013-09-10 Impact factor: 4.177
Authors: Willemijn L Eppenga; Cornelis Kramers; Hieronymus J Derijks; Michel Wensing; Jack F M Wetzels; Peter A G M De Smet Journal: PLoS One Date: 2015-03-05 Impact factor: 3.240
Authors: Bhavna Bhasin; Bryan Lau; Mohamed G Atta; Derek M Fine; Michelle M Estrella; George J Schwartz; Gregory M Lucas Journal: PLoS One Date: 2013-12-23 Impact factor: 3.240